FDA Weighs Peptide Safety Amid Industry Ties | Irvine News

Presented by The Plant Daddies — rare specimen trees, living art, and hand-carved limestone vessels and fountains for extraordinary spaces. Showrooms in Los Angeles and Irvine. Listeners of Irvine News Today receive 10% off with code LANEWS10. theplantdaddies.com/lanews Health advisors are weighing whether to greenlight seven popular peptides—widely used for everything from muscle building to anti-aging, despite shaky science—amid concerns over safety and conflicts of interest, as Health Secretary Robert F. Kennedy Jr. pushes for looser rules. While some peptides are FDA-approved for specific conditions, most being discussed are off-label, with little clinical proof backing their use, especially when compounded. Experts warn of risks as people self-administer unproven treatments, and critics highlight that some advisors have ties to the very industries they’re supposed to regulate. The vote isn’t binding, but with Kennedy’s backing, legal analysts expect a tilt toward expanding access—even if formal changes take time. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9bae143305e660c8